Leadership Overview
USV Private has 8 executives leading key functions including information technology, financial management, human resources, operations, biologics, sales, marketing, and corporate strategy.
Driven by a commitment to pharmaceutical excellence, USV Private advances global health through the development of high-quality biotechnology solutions and innovative manufacturing processes that improve patient outcomes worldwide.
Driven by a commitment to pharmaceutical excellence, USV Private advances global health through the development of high-quality biotechnology solutions and innovative manufacturing processes that improve patient outcomes worldwide.
Leadership Roles at USV Private
Jogendra Sethi - Chief Financial Officer
Jogendra Sethi, the Chief Financial Officer at USV Private, manages the fiscal health and capital allocation strategies for the multinational biotechnology firm. Overseeing global financial reporting, the Chief Financial Officer ensures compliance with international regulatory standards while driving profitability across diverse product lines. This leadership role involves evaluating investment opportunities in new drug development and manufacturing capacity expansion. By optimizing the balance sheet, Jogendra Sethi directly impacts the long-term financial stability of the organization. Furthermore, Sethi coordinates with the Board to align budgetary priorities with the strategic goals of the company. Through rigorous cost management and revenue forecasting, the Chief Financial Officer maintains the liquidity required for sustained research and development initiatives. Ultimately, Sethi secures the financial resources necessary to support the expansion of pharmaceutical operations, ensuring that the company remains a leader in the global biotechnology sector through disciplined fiscal oversight and strategic resource management.
Jayant Dwivedy - Executive Director & Chief Operating Officer
Jayant Dwivedy, the Executive Director & Chief Operating Officer at USV Private, directs the daily manufacturing and operational activities of the multinational pharmaceutical company. Overseeing the entire production lifecycle, the Executive Director & Chief Operating Officer ensures that biotechnology facilities operate at peak efficiency while adhering to strict quality control protocols. This leadership role involves coordinating cross-functional teams to streamline the transition from research to large-scale manufacturing. By optimizing supply chain logistics, Jayant Dwivedy directly impacts the availability of essential medications in global markets. Furthermore, Dwivedy manages the integration of new manufacturing technologies to enhance output and reduce waste. Through the oversight of operational safety and compliance, the Executive Director & Chief Operating Officer maintains the integrity of the production process. Ultimately, Dwivedy secures the operational excellence required to meet the growing demand for high-quality pharmaceutical products, ensuring that manufacturing capabilities remain aligned with the company's strategic growth objectives.
Esmail Samiwala - President, Biologics
Esmail Samiwala, the President, Biologics at USV Private, leads the specialized division focused on the development and commercialization of complex biological therapies. Overseeing the research pipeline for biologics, the President, Biologics ensures that innovative treatments move efficiently through clinical trials to market launch. This leadership role involves managing partnerships with research institutions to advance the company's biotechnology portfolio. By directing the scientific strategy for new drug candidates, Esmail Samiwala directly impacts the therapeutic impact of the company's offerings. Furthermore, Samiwala coordinates with regulatory bodies to ensure that all biological products meet stringent safety and efficacy standards. Through the expansion of the biologics manufacturing footprint, the President, Biologics maintains the capacity to serve patients with chronic conditions. Ultimately, Samiwala secures the future of the company's biologics segment, ensuring that the organization remains at the forefront of medical innovation through the development of advanced therapeutic solutions.
Singh Yogender - President (Sales & Marketing)
Singh Yogender, the President (Sales & Marketing) at USV Private, directs the commercial strategy and market penetration efforts for the pharmaceutical portfolio. Overseeing global sales teams, the President (Sales & Marketing) ensures that high-quality biotechnology products reach healthcare providers and patients effectively. This leadership role involves analyzing market trends to identify growth opportunities in emerging and established regions. By optimizing the distribution network, Singh Yogender directly impacts the market share of the company's core products. Furthermore, Yogender manages marketing campaigns that communicate the value and efficacy of the company's pharmaceutical solutions to medical professionals. Through the alignment of sales targets with production capabilities, the President (Sales & Marketing) maintains a consistent revenue stream. Ultimately, Yogender secures the commercial success of the organization, ensuring that the company's innovative medical products are accessible to those in need while driving sustainable growth across all international markets.
Sunil Bhutani - President
Sunil Bhutani, the President at USV Private, oversees the strategic direction and corporate governance of the multinational pharmaceutical organization. Directing the long-term vision, the President ensures that all business units remain focused on the core mission of advancing biotechnology and pharmaceutical manufacturing. This leadership role involves coordinating with the Board to evaluate market expansion strategies and capital investments. By fostering relationships with key stakeholders, Sunil Bhutani directly impacts the reputation and influence of the company in the global healthcare sector. Furthermore, Bhutani manages the integration of new business initiatives to diversify the product portfolio. Through the oversight of corporate policy and ethical standards, the President maintains the integrity of the organization's operations. Ultimately, Bhutani secures the strategic alignment of the company, ensuring that all departments work in concert to deliver high-quality medical solutions while achieving sustainable growth and maintaining a strong competitive position in the international market.
Anuj Maheshwari - President
Anuj Maheshwari, the President at USV Private, manages the operational execution of strategic initiatives across the pharmaceutical and biotechnology divisions. Overseeing the implementation of corporate policies, the President ensures that all departments adhere to the high standards of quality and innovation expected of the company. This leadership role involves optimizing internal processes to improve efficiency and reduce time-to-market for new pharmaceutical products. By facilitating cross-departmental collaboration, Anuj Maheshwari directly impacts the agility of the organization. Furthermore, Maheshwari manages the expansion of the company's footprint in key international markets, ensuring that operational capabilities meet local demand. Through the monitoring of performance metrics, the President maintains accountability across all functional areas. Ultimately, Maheshwari secures the operational success of the organization, ensuring that the company's strategic goals are translated into tangible results that improve patient health and strengthen the company's position as a leader in the global pharmaceutical industry.
Govind Joshi - Chief Information Officer
Govind Joshi, the Chief Information Officer at USV Private, directs the digital transformation of pharmaceutical manufacturing systems. Overseeing enterprise-wide data security, the Chief Information Officer ensures robust protection for proprietary biotechnology research. This leadership role involves integrating advanced analytics into supply chain management to optimize production efficiency across international markets. By modernizing legacy infrastructure, Govind Joshi directly impacts the agility of the organization. Furthermore, Joshi manages the deployment of cloud-based platforms that support real-time collaboration between research laboratories and manufacturing facilities. Through the implementation of automated reporting tools, the Chief Information Officer maintains high standards of data integrity. Ultimately, Joshi secures the technological foundation necessary for sustained growth in the competitive global pharmaceutical landscape, ensuring that all digital assets align with the core mission of delivering life-saving medical products to diverse patient populations.
Aparna Vishwasrao - Chief Human Resources Officer
Aparna Vishwasrao, the Chief Human Resources Officer at USV Private, architects the talent acquisition and organizational development strategies for the pharmaceutical enterprise. Overseeing global workforce planning, the Chief Human Resources Officer ensures the alignment of human capital with the complex requirements of biotechnology manufacturing. This leadership role involves fostering a culture of innovation and scientific excellence across all regional offices. By implementing comprehensive training programs, Aparna Vishwasrao directly impacts the technical proficiency of the workforce. Furthermore, Vishwasrao manages performance management systems that incentivize high-level contributions to drug development and operational efficiency. Through the cultivation of diverse talent pipelines, the Chief Human Resources Officer maintains a competitive edge in the global labor market. Ultimately, Vishwasrao secures the organizational health necessary for long-term success, ensuring that the company attracts and retains the specialized expertise required to advance pharmaceutical research and maintain high manufacturing standards.
Explore Leadership Teams in Manufacturing
Founded in 2020, Viatris empowers people worldwide to live healthier at every stage of life. They provide access to medicines, advance sustainable operations, develop innovative solutions, and leverage their collective expertise to improve patient health. Viatris is headquartered in Canonsburg, Pennsylvania.
Company Leadership JG
ZW
Founded in 1989, Macleods Pharmaceutical develops and manufactures generic pharmaceuticals. The Company offers tablets, drugs, syrup, and other related products. The company is headquartered in Mumbai, Maharashtra, India.
Company Leadership BP
AS
MP
AM
Founded in 1973 and headquartered in Bangalore, India, Micro Lab is a pharmaceutical manufacturer, wholesaler, and R&D company.
Company Leadership MH
RK
JL
PM
Soft gelatin capsule products, liquid preparations, medicinal plasters, ointments, and creams are produced at the Gunung Putri Plant. In producing these products, Gunung Putri Plant implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 and ISO 22000:2018 certificates. Meanwhile, sterile injection products and solid preparations in the form of tablets and capsules are produced at the Citeureup Plant. The Citeureup Plant also implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and SNI ISO/IEC 17025:2017 certificates. In running the Toll Manufacturing business, Darya-Varia collaborates with an affiliated company, PT Medifarma Laboratories, at the Cimanggis Depok Plant. The Company has been trusted by local business partners and both for the domestic and international markets for the Export & Toll Manufacturing business and conducts technology transfer, lab and pilot trials, stability studies, procurement of raw materials and packaging, and commercial production of high-quality finished goods. Darya-Varia always ensures the quality and safety of each product, so that all of its products are certified halal. All plant facilities owned by Darya-Varia have implemented the halal guarantee system. Blue Sphere Singapore Pte Ltd (BSSPL) owns 92.13% stake in Darya-Varia. For 45 years, Darya-Varia has continued to progress in providing high quality health facilities. Through the mission of "building a healthier Indonesia for everyone one person at a time", Darya-Varia is always committed to providing a variety of quality products with the right strategy for the health of the Indonesian people. DARYA VARIA
Company Leadership CH
Frequently Asked Questions Regarding USV Private Top Executives and Leadership Team
